Jones, Scott

Your profile? Update now
Updated 03/30/10

firm image

Jones Day

Kamiyacho Prime Place
1-17, Toranomon 4-chome

Minato-ku, Tokyo 105-0001, Japan

Phone: 81.3.6800.1813 (Business Phone)

Fax: 81.3.5401.2725 (Business Fax)

Contact Us (Business Email)

Websites associated with this firm:http://www.jonesday.com

Summary

Current Employment Position(s)

Partner

Languages

  • English
  • Japanese

Lawyer Overview

Scott Jones has more than 20 years of experience in the fields of M&A, corporate law, and arbitration and represents Japanese clients in their investments overseas and foreign clients in connection with their investments in Japan. He has significant experience in cross-border investments, corporate acquisitions, joint ventures, and licensing agreements.

Scott has a strong technical background and has represented many chemical, pharmaceutical, and high-technology companies, both Japanese and foreign. Scott also has significant arbitration experience, having represented clients in proceedings governed by the rules of the American Arbitration Association, the International Chamber of Commerce, and the Japan Commercial Arbitration Association.

Scott represented Daiichi Sankyo in its purchase of a majority equity interest in Ranbaxy Laboratories Limited for approximately US$4 billion and Sumitomo Pharmaceuticals Co. in its merger with Dainippon Pharmaceutical Co. in a transaction valued at approximately US$2 billion.

After graduating from college, Scott worked as a process engineer at Intel Corporation.

Areas of Practice

  • Mergers & Acquisitions
  • Intellectual Property
  • International Litigation & Arbitration
  • M&A
  • Licensing & Technology Transactions
  • Life Sciences

Representative Cases

  • adidas Japan KK receives tender offer from Salomon
  • ALM involved in arbitration proceedings in connection with dispute with Kirschner Medical Corp.
  • Daiichi Pharmaceutical merges with Sankyo Co.
  • Daiichi Sankyo acquires generic-drug maker Ranbaxy Laboratories for $4.6 billion
  • International Herald Tribune establishes joint venture with Asahi Shimbun
  • Japanese outboard engine company involved in arbitration in connection with a supply agreement
  • Societe BIC S.A. purchases distributor of BIC products in Japan
  • Sumitomo Chemical forms joint venture with Lyondell Chemical Corporation , (2009)
  • Sumitomo merges with Dainippon Pharmaceutical

West Practice Categories

Business Organizations, Business Successions, Closely Held Businesses, Copyrights, Corporate Governance, Directors' & Officers' Liability, Dissolution, Formation & Business Planning, Franchising, Intellectual Property Law, International Intellectual Property, Joint Ventures, Limited Liability Companies, Mergers, Acquisitions & Divestitures, Non-profit & Tax-exempt Organizations, Partnerships, Patents, Reorganizations, Shareholders' Rights, Technology Licensing, Trade Associations, Trade Dress, Trade Secrets, Trademarks

Qualifications

Bar Admissions

  • New York
  • Japan (Gaikokuho Jimu Bengoshi)

Education

  • Columbia University - New York
  • U of California - Santa Cruz

Articles

Published Works

  • Recent Developments in Takeover Defense Discussions in Japan, 2008
  • Recent Revisions to Japanese Tender Offer Rules: Toward Transparency and Fairness, 2007
  • Hostile Takeover Attempt and Poison Pills in a Japanese Way: Livedoor vs. Fuji TV over Nippon Broadcasting, The M&A Lawyer, 2005
  • Basic Understandings of M&A Agreements I/II, M&A Review, 2005

Office Information

Address

Kamiyacho Prime Place
1-17, Toranomon 4-chome
Minato-ku, Tokyo 105-0001, Japan

Phones

81.3.6800.1813 (Business Phone)

Faxes

81.3.5401.2725 (Business Fax)

Emails

Contact Us (Business Email)

Websites

http://www.jonesday.com

When viewing a listing, consider the state advertising restrictions to which lawyers and law firms must adhere, as well as our West Legal Directory disclaimers. Some lawyers publish comparative information regarding the services that they provide which may be subject to specific comparative communications restrictions.